Inflammation and oxidative stress in end-stage renal disease patients treated with hemodialysis or peritoneal dialysis

被引:48
|
作者
Filiopoulos, Vassilis [1 ]
Hadjiyannakos, Dimitrios [1 ]
Takouli, Lambrini [1 ]
Metaxaki, Polixeni [1 ]
Sideris, Vasilis [2 ]
Vlassopoulos, Dimosthenis [1 ]
机构
[1] Amalia Fleming Hosp, Dept Nephrol, Athens 14121, Greece
[2] Pendeli Pediat Hosp, Dept Hematol, Athens, Greece
来源
关键词
End-stage renal disease; Hemodialysis; Peritoneal dialysis; Inflammation; Oxidative stress; C-REACTIVE-PROTEIN; ENDOTHELIAL DYSFUNCTION; CARDIOVASCULAR-DISEASE; HYPERHOMOCYSTEINEMIA; MICROINFLAMMATION; DYSLIPIDEMIA; SERUM; IRON;
D O I
10.1177/039139880903201206
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Purpose: The impact of different dialysis modalities on oxidative stress and inflammation and the factors implicated in this interrelationship have not been adequately studied. This study was designed to comparatively evaluate the effect of hemodialysis (HD) and peritoneal dialysis (PD) on oxidative stress and inflammatory biomarkers and to search for associated factors. Methods: We studied 20 HD, 11 PD patients and 11 healthy controls. Calculations were based on total antioxidant capacity (TAC) and superoxide dismutase (SOD), by spectrophotometry, as oxidative stress biomarkers; and high sensitivity CRP (hs-CRP), Interleukin-6 (IL-6) and Tumor Necrosis Factor-alpha (TNF-alpha), by ELISA, as inflammation biomarkers. Results: HD and PD patients showed significantly increased levels of TAC, SOD and hs-CRP compared to healthy controls. No significant difference was observed in TNF-alpha and IL-6. Compared to HD patients, PD patients showed TNF-alpha levels that were increased, although non-significantly, and significantly higher homocysteine (Hcy). No differences were observed for IL-6, hs-CRP, TAC and SOD. In HD patients, significant positive correlations were found between intact parathyroid hormone (iPTH) and TNF-alpha, and between uric acid (UA) and TAC. beta 2-microglobulin (beta 2M) was negatively correlated with TAC, total cholesterol (TC) positively with TNF-alpha and negatively with SOD, and triglycerides (TG) correlated positively with TNF-alpha. In PD patients, TG correlated positively with TNF-alpha, HDL-cholesterol negatively with TNF-alpha, LDL-cholesterol negatively with SOD, and beta 2M negatively with SOD. Conclusions: HD and PD patients show similar degrees of inflammation and oxidative stress activation. Factors such as UA, iPTH, beta 2M and lipid profile correlate to oxidative stress and inflammatory biomarkers in both HD and PD patients. (Int J Artif Organs 2009; 32: 872-82)
引用
收藏
页码:872 / 882
页数:11
相关论文
共 50 条
  • [21] Peritoneal dialysis in children with end-stage renal disease
    Franz Schaefer
    Bradley A. Warady
    [J]. Nature Reviews Nephrology, 2011, 7 : 659 - 668
  • [22] PERITONEAL DIALYSIS FOR PATIENTS WITH END-STAGE RENAL DISEASE AND LIVER CIRRHOSIS
    Khan, Sana
    Rosner, Mitchell H.
    [J]. PERITONEAL DIALYSIS INTERNATIONAL, 2018, 38 (06): : 397 - 401
  • [23] Peritoneal dialysis in children with end-stage renal disease
    Schaefer, Franz
    Warady, Bradley A.
    [J]. NATURE REVIEWS NEPHROLOGY, 2011, 7 (11) : 659 - 668
  • [24] Proenkephalin Levels and Its Determinants in Patients with End-Stage Kidney Disease Treated with Hemodialysis and Peritoneal Dialysis
    Grycuk, Wiktoria
    Jakubowska, Zuzanna
    Malyszko, Jolanta
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (19)
  • [25] IN-HOSPITAL MORTALITY IN CIRRHOTIC PATIENTS WITH END-STAGE RENAL DISEASE TREATED WITH HEMODIALYSIS VERSUS PERITONEAL DIALYSIS: A NATIONWIDE STUDY
    Nader, Mark A.
    Aguilar, Rodrigo
    Sharma, Prabin
    Krishnamoorthy, Parasuram
    Serban, Dragoi
    Gordon-Cappitelli, Judit
    Shen, Wen
    Nilubol, Chanigan
    Li, Ping
    Lipkowitz, Michael
    [J]. PERITONEAL DIALYSIS INTERNATIONAL, 2017, 37 (04): : 464 - 471
  • [26] Is there different risk of cancer among end-stage renal disease patients undergoing hemodialysis and peritoneal dialysis?
    Lee, Yi-Che
    Hung, Shih-Yuan
    Wang, Hao-Kuang
    Lin, Chi-Wei
    Wang, Hsi-Hao
    Chang, Min-Yu
    Sung, Junne-Ming
    Chiou, Yuan-Yow
    Lin, Sheng-Hsiang
    [J]. CANCER MEDICINE, 2018, 7 (02): : 485 - 498
  • [27] Review of combination of peritoneal dialysis and hemodialysis as a modality of treatment for end-stage renal disease
    Fukui, H
    Hara, S
    Hashimoto, Y
    Horiuchi, T
    Ikezoe, M
    Itami, N
    Kawabe, M
    Kawanishi, H
    Kimura, Y
    Nakamoto, H
    Nakayama, M
    Ono, M
    Ota, K
    Shinoda, T
    Suga, T
    Ueda, T
    Fujishima, M
    Maeba, T
    Yamashita, A
    Yoshino, Y
    Watanabe, S
    Watanabe, T
    [J]. THERAPEUTIC APHERESIS AND DIALYSIS, 2004, 8 (01) : 56 - 61
  • [28] Removal of methotrexate by peritoneal dialysis and hemodialysis in a single patient with end-stage renal disease
    Diskin, Charles J.
    Stokes, Thomas J.
    Dansby, Linda M.
    Radcliff, Lautrec
    Carter, Thomas B.
    [J]. AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2006, 332 (03): : 156 - 158
  • [29] Risk of hemodialysis against peritoneal dialysis for chronic heart failure in patients with end-stage renal disease
    Kawada, Tomoyuki
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 223 : 360 - 360
  • [30] Effect of renal transplantation on biomarkers of inflammation and oxidative stress in end-stage renal disease patients
    Simmons, EM
    Langone, A
    Sezer, MT
    Vella, JP
    Recupero, P
    Morrow, JD
    Ikizler, TA
    Himmelfarb, J
    [J]. TRANSPLANTATION, 2005, 79 (08) : 914 - 919